A novel nuclear inhibitor I-92 regulates DNA binding activity of octamer binding protein p92 during the cell cycle

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Jürgen Weitz - , German Cancer Research Center (DKFZ) (Author)
  • Marijana Kopun - , German Cancer Research Center (DKFZ) (Author)
  • M. Stoehr - , German Cancer Research Center (DKFZ) (Author)
  • Inge Napierski - , German Cancer Research Center (DKFZ) (Author)
  • Hans dieter Royer - , German Cancer Research Center (DKFZ) (Author)

Abstract

Nuclear DNA binding protein p92 is a sequence specific octamer binding protein with identical molecular weight as the ubiquitous octamer binding protein Oct-1. It binds to octamer related sequences from the enhancer of human papillomavirus type 18. The activity and intracellular distribution of p92 is regulated by extracellular signals. In serum starved Hela-fibroblast hybrid cells p92 is localized to the cytosol. Serum stimulation leads to nuclear import of p92. In fractions of asynchronously growing cells, which were separated according to cell cycle phases into G1, S, and G2 populations by centrifugal elutriation, p92 DNA binding is confined to S phase. In binding site blots however, p92 DNA binding activity is also present in G1 and G2. In G1 and G2 DNA binding activity of p92 is masked by a novel nuclear inhibitor I-92. The cyclic association of p92 with its inhibitor I-92 provides a new mechanism of regulating S phase dependent activity of a sequence specific DNA binding protein.

Details

Original languageEnglish
Pages (from-to)5725-5730
Number of pages6
JournalNucleic acids research
Volume19
Issue number20
Publication statusPublished - 25 Oct 1991
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 1945850

Keywords

ASJC Scopus subject areas